InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,476.49
(
-0.03%
)
US TECH 100
19,228.80
(
0.07%
)
Dow Jones
39,177.16
(
0.13%
)
Brent Oil
85.24
(
0.91%
)
Bitcoin
61,725.62
(
1.50%
)
Post# of 2070
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bowonwing

Send PM Follow Ignore
Followers 4
Posts 930
Boards Moderated 0
Alias Born 06/25/2007

bowonwing

Re: None

Thursday, 06/28/2007 11:23:12 PM

Thursday, June 28, 2007 11:23:12 PM

Post# of 2070
". ... (T)he development of innovative products that activate the immune system to treat cancer."

Is this developmental approach novel to IDMI?

Are there any competitors using the same development approach?

Excuse me if these questions are pedestrian, I am new to biotech stocks. It sounds like such a promising approach to treat cancer.

Thanking you in advance for any comments.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!